» Articles » PMID: 29130940

Neuropeptide Y Regulates a Vascular Gateway for Hematopoietic Stem and Progenitor Cells

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2017 Nov 14
PMID 29130940
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Endothelial cells (ECs) are components of the hematopoietic microenvironment and regulate hematopoietic stem and progenitor cell (HSPC) homeostasis. Cytokine treatments that cause HSPC trafficking to peripheral blood are associated with an increase in dipeptidylpeptidase 4/CD26 (DPP4/CD26), an enzyme that truncates the neurotransmitter neuropeptide Y (NPY). Here, we show that enzymatically altered NPY signaling in ECs caused reduced VE-cadherin and CD31 expression along EC junctions, resulting in increased vascular permeability and HSPC egress. Moreover, selective NPY2 and NPY5 receptor antagonists restored vascular integrity and limited HSPC mobilization, demonstrating that the enzymatically controlled vascular gateway specifically opens by cleavage of NPY by CD26 signaling via NPY2 and NPY5 receptors. Mice lacking CD26 or NPY exhibited impaired HSPC trafficking that was restored by treatment with truncated NPY. Thus, our results point to ECs as gatekeepers of HSPC trafficking and identify a CD26-mediated NPY axis that has potential as a pharmacologic target to regulate hematopoietic trafficking in homeostatic and stress conditions.

Citing Articles

Systemic and local regulation of hematopoietic homeostasis in health and disease.

Carpenter R, Maryanovich M Nat Cardiovasc Res. 2024; 3(6):651-665.

PMID: 39196230 DOI: 10.1038/s44161-024-00482-4.


Role of Neurotransmitters in Steady State Hematopoiesis, Aging, and Leukemia.

Beeraka N, Basappa B, Nikolenko V, Mahesh P Stem Cell Rev Rep. 2024; 21(1):2-27.

PMID: 38976142 DOI: 10.1007/s12015-024-10761-z.


Platelet-derived circulating soluble P-selectin is sufficient to induce hematopoietic stem cell mobilization.

Wang T, Liou Y, Yang S, Lin G, Chiang Y, Lien T Stem Cell Res Ther. 2023; 14(1):300.

PMID: 37864264 PMC: 10589967. DOI: 10.1186/s13287-023-03527-w.


Hematopoietic stem cell mobilization.

Chang H, Liou Y, Sun D Tzu Chi Med J. 2022; 34(3):270-275.

PMID: 35912054 PMC: 9333105. DOI: 10.4103/tcmj.tcmj_98_21.


Neuropeptide Y: An Update on the Mechanism Underlying Chronic Intermittent Hypoxia-Induced Endothelial Dysfunction.

Li M, Zheng Y, Wang W, Lin S, Lin H Front Physiol. 2021; 12:712281.

PMID: 34512386 PMC: 8430344. DOI: 10.3389/fphys.2021.712281.


References
1.
Park M, Lee J, Kim N, Min W, Lee J, Kim K . Neuropeptide Y Induces Hematopoietic Stem/Progenitor Cell Mobilization by Regulating Matrix Metalloproteinase-9 Activity Through Y1 Receptor in Osteoblasts. Stem Cells. 2016; 34(8):2145-56. DOI: 10.1002/stem.2383. View

2.
Lambeir A, Proost P, Durinx C, Bal G, Senten K, Augustyns K . Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family. J Biol Chem. 2001; 276(32):29839-45. DOI: 10.1074/jbc.M103106200. View

3.
Proost P, Struyf S, Schols D, Durinx C, Wuyts A, Lenaerts J . Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha. FEBS Lett. 1998; 432(1-2):73-6. DOI: 10.1016/s0014-5793(98)00830-8. View

4.
Smith-Berdan S, Nguyen A, Hong M, Forsberg E . ROBO4-mediated vascular integrity regulates the directionality of hematopoietic stem cell trafficking. Stem Cell Reports. 2015; 4(2):255-68. PMC: 4325232. DOI: 10.1016/j.stemcr.2014.12.013. View

5.
Christopherson 2nd K, Cooper S, Broxmeyer H . Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells. Blood. 2003; 101(12):4680-6. DOI: 10.1182/blood-2002-12-3893. View